1097834-07-5

Basic information

• Product Name: benzyl 4-((2-(tert-butoxycarbonylamino)ethyl)(4-chlorobenzyl)carbamoyl)piperazine-1-carboxylate
• Synonyms: benzyl 4-((2-(tert-butoxycarbonylamino)ethyl)(4-chlorobenzyl)carbamoyl)piperazine-1-carboxylate;4-[[[(4-Chlorophenyl)methyl][2-[[(tert-butoxy)carbonyl]amino]ethyl]amino]carbonyl]-1-piperazinecarboxylic acid benzyl ester
• CAS NO: 1097834-07-5
• Molecular Formula: C₂₇H₃₅ClN₄O₅
• Molecular Weight: 531.0436
• Mol File: 1097834-07-5.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• Density: 1.246
• CAS DataBase Reference: benzyl 4-((2-(tert-butoxycarbonylamino)ethyl)(4-chlorobenzyl)carbamoyl)piperazine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: benzyl 4-((2-(tert-butoxycarbonylamino)ethyl)(4-chlorobenzyl)carbamoyl)piperazine-1-carboxylate(1097834-07-5)
• EPA Substance Registry System: benzyl 4-((2-(tert-butoxycarbonylamino)ethyl)(4-chlorobenzyl)carbamoyl)piperazine-1-carboxylate(1097834-07-5)

Safety Data

• Hazardous Substances Data: 1097834-07-5(Hazardous Substances Data)

Usage

General Description

Benzyl 4-((2-(tert-butoxycarbonylamino)ethyl)(4-chlorobenzyl)carbamoyl)piperazine-1-carboxylate is a complex chemical compound with a long name. It belongs to the class of piperazine derivatives, which are often used in pharmaceuticals. The compound contains benzyl, 4-chlorobenzyl, and piperazine moieties, as well as a carboxylate group. It also features a tert-butoxycarbonylaminoethyl group. This chemical may have potential applications in the field of medicinal chemistry, particularly in the development of new drugs or pharmaceuticals. Further research and analysis would be required to fully understand its properties and potential uses.

Upstream product

• 25539-27-9 4-chlorocarbonyl-piperazine-1-carboxylic acid benzyl ester 
• 335059-94-4 [2-(4-chlorobenzylamino)ethyl]carbamic acid tert-butyl ester 

Downstream Products

• 1097834-08-6 tert-butyl 2-(N-(4-chlorobenzyl)piperazine-1-carboxamido)ethylcarbamate 

Relevant articles and documents

PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS

The present invention provides compounds of Formula I, including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof. Also provided are methods of using the compounds of this invent